Monday, November 25, 2024

FDA awards BIMO Program Strategic Support task

Sagacity Ventures, a joint venture between Accel Solutions and Cognizance Technologies, has been awarded a 14-month, $1M task by the Food and Drug Administration to provide Bioresearch Monitoring (BIMO) program strategic support. This task was awarded on the GSA 8(a) STARS III contract vehicle.

Awardee Name SAGACITY VENTURES LLC
Contract Duration 14 month
Total Contract Value $959256.37
Funding Agency FOOD AND DRUG ADMINISTRATION
Funding Office FDA OFFICE OF ACQ GRANT SVCS
Number of Bidders 1
Set Aside Used
RFP ID
Award ID 75F40123F80217
Referenced IDV ID 47QTCB21D0429
Action Obligation $959256.37
UEI H1S1ULWVRYK8
Department Name HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Start Date 2023-07-26 00:00:00
Ultimate Completion Date 2024-09-26 00:00:00
NAICS 541512
Contract Type LABOR HOURS
Contract Vehicle GSA 8(a) STARS III

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Subscribe to our mailing list

* indicates required